Stem cells produce blood vessels using novel vasculogenic method

07/30/2013 | MedicalXpress.com

Researchers at Massachusetts General Hospital and Harvard University were able to produce endothelial cells and multipotent stromal cells from human induced pluripotent stem cells and use them to generate blood vessels in vivo. "To our knowledge, this is the first report demonstrating the use of triple selection markers CD34, NP1 and KDR for the isolation of vasculogenic precursor cells from human induced pluripotent stem cells that are, most importantly, highly potent in an in vivo setting," according to one of the researchers.

View Full Article in:

MedicalXpress.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX